Graham Doyle

Stock Analyst at UBS

(2.03)
# 3,073
Out of 5,032 analysts
11
Total ratings
60%
Success rate
4.18%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Sep 2, 2025
Downgrades: Sell
Price Target: n/a
Current: $27.16
Upside: -
GE HealthCare Technologies
May 5, 2025
Upgrades: Neutral
Price Target: $74$73
Current: $74.05
Upside: -1.42%
Smith & Nephew
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $36.34
Upside: -
Koninklijke Philips
Feb 20, 2025
Upgrades: Buy
Price Target: n/a
Current: $28.52
Upside: -